Lilly and Boehringer Ingelheim present health outcomes data for investigational novel basal insulin analogue
Patient-reported health outcomes data from a Phase II study...
2 October 2012 | By Boehringer Ingelheim
Patient-reported health outcomes data from a Phase II study...